MARKET RASEN SURGERY — All Prescriptions & Medications — Page 13
Practice Code: C83043 | MARKET RASEN, LN8 3BP
Showing results 601-650 of 696
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Fluticasone propionate (Nasal) | 16 | 16 | £159 | -89.0% ▼ |
| 16 | 170 | £361 | -38.3% ▼ | |
| 16 | 1,895 | £3.3K | -13.1% ▼ | |
| 16 | 675 | £1.5K | +52.3% ▲ | |
| Metolazone | 15 | 84 | £276 | +112.6% ▲ |
| Heparin flushes | 15 | 150 | £273 | +324.1% ▲ |
| Hyoscine hydrobromide | 15 | 444 | £75 | -56.1% ▼ |
| 15 | 19 | £49 | +174.2% ▲ | |
| 15 | 335 | £54 | +25.8% ▲ | |
| 15 | 540 | £1.0K | +1.0% vs avg | |
| Phosphates (Rectal) | 14 | 166 | £5.7K | +14.5% ▲ |
| Aspirin | 14 | 484 | £67 | +42.5% ▲ |
| Bupropion hydrochloride | 14 | 836 | £530 | +29.5% ▲ |
| Insulin glulisine | 14 | 33 | £427 | -34.7% ▼ |
| Metformin hydrochloride/pioglitazone | 14 | 784 | £533 | +10.8% ▲ |
| Indoramin | 14 | 900 | £777 | -7.9% ▼ |
| Fesoterodine fumarate | 14 | 385 | £35 | -64.5% ▼ |
| Triptorelin | 14 | 14 | £2.6K | -33.6% ▼ |
| Ready to serve 4.5 - 5 kcal/ml energy (fat) liquid (0913142) | 14 | 44.6K | £1.3K | +24.9% ▲ |
| Ketorolac trometamol | 14 | 70 | £62 | +50.9% ▲ |
| Ipratropium bromide | 14 | 14 | £99 | -13.7% ▼ |
| Chlorhexidine gluconate | 14 | 4,500 | £29 | -36.3% ▼ |
| Medicated stockings | 14 | 90 | £318 | +107.8% ▲ |
| 14 | 87 | £41 | +59.3% ▲ | |
| 14 | 600 | £1.5K | -8.1% ▼ | |
| Linaclotide | 13 | 364 | £434 | -28.8% ▼ |
| Minoxidil | 13 | 780 | £110 | +16.6% ▲ |
| Trandolapril | 13 | 476 | £38 | +25.0% ▲ |
| Gemfibrozil | 13 | 728 | £439 | +28.7% ▲ |
| Levocetirizine | 13 | 390 | £50 | -16.6% ▼ |
| Reboxetine | 13 | 375 | £105 | -15.6% ▼ |
| Cenobamate | 13 | 364 | £2.1K | -46.3% ▼ |
| Levocarnitine | 13 | 3,120 | £9.9K | +75.9% ▲ |
| RtS 1.5 - 1.6 kcal/ml milkshake with fibre (0913011) | 13 | 10.0K | £133 | -2.2% ▼ |
| 13 | 76 | £677 | -26.0% ▼ | |
| 13 | 85 | £281 | -4.7% ▼ | |
| 13 | 780 | £1.2K | +32.9% ▲ | |
| 13 | 32 | £458 | -18.7% ▼ | |
| 13 | 555 | £1.4K | -8.1% ▼ | |
| 13 | 230 | £1.6K | +48.6% ▲ | |
| 13 | 560 | £3.6K | +43.0% ▲ | |
| Irbesartan with diuretic | 12 | 336 | £83 | -23.7% ▼ |
| Olmesartan medoxomil/amlodipine/hydrochlorothiazide | 12 | 336 | £181 | -24.1% ▼ |
| Ipratropium bromide | 12 | 12 | £61 | -58.3% ▼ |
| Rufinamide | 12 | 660 | £1.0K | -30.1% ▼ |
| Phenobarbital | 12 | 1,344 | £35 | -61.0% ▼ |
| Vildagliptin | 12 | 672 | £195 | -17.3% ▼ |
| Betamethasone sodium phosphate | 12 | 1,050 | £149 | -2.4% ▼ |
| Mycophenolic sodium | 12 | 960 | £1.4K | +23.0% ▲ |
| Lanreotide | 12 | 12 | £10.0K | +30.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.